Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.33B 940M 814M 763M 696M 1.31B 89.63B 1.33B 8.99B 3.5B 44.92B 3.53B 3.45B 150B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.21B 1.07B 927M 869M 792M 1.49B 102B 1.52B 10.23B 3.99B 51.13B 4.02B 3.93B 171B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day+1.31%
1 week+1.53%
Current month+0.87%
1 month+2.88%
3 months-6.64%
6 months+2.65%
Current year+6.67%
1 week 4.51
Extreme 4.51
4.68
1 month 4.36
Extreme 4.36
4.83
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.54
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Chairman 56 2026-03-26
Director/Board Member 58 2007-12-24
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Director

3,670,000 0.4719%
9/18/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+1.53%-24.18%-42.86% 927M
-0.55%-2.22%-9.75%-7.08% 13.44B
-1.21%-2.99%+3.32%+2.62% 5.07B
-0.04%-3.45%-32.04%-56.12% 5.06B
-0.53%-0.06%+3.64%-31.14% 4.18B
-0.19%-2.88%-13.29%-5.97% 3.66B
-1.79%-4.51%-5.37%+0.44% 3.5B
-1.42%-3.41%-5.90%+14.85% 3.44B
+0.44%+0.44%-13.28%-15.72% 2.47B
-9.22%-10.30%-11.84%+29.56% 1.88B
Average -1.32%-0.96%-10.87%-11.14% 4.36B
Weighted average by Cap. -0.98%-0.76%-9.77%-11.19%

Financials

2024 2025
Net sales 3.83B 568M 492M 461M 420M 790M 54.13B 804M 5.43B 2.12B 27.13B 2.13B 2.09B 90.54B 3.05B 453M 392M 367M 335M 630M 43.14B 641M 4.33B 1.69B 21.62B 1.7B 1.66B 72.15B
Net income 33.62M 4.99M 4.32M 4.05M 3.69M 6.94M 476M 7.07M 47.72M 18.6M 238M 18.74M 18.33M 796M -104M -15.49M -13.42M -12.58M -11.46M -21.56M -1.48B -21.95M -148M -57.73M -740M -58.17M -56.91M -2.47B
Net Debt 1.4B 208M 180M 169M 154M 289M 19.82B 294M 1.99B 775M 9.93B 780M 764M 33.14B 875M 130M 112M 105M 96.05M 181M 12.38B 184M 1.24B 484M 6.2B 488M 477M 20.7B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-08-12 CN¥4.640 +1.31% 8,100,200
26-08-11 CN¥4.580 -0.22% 9,896,900
26-08-10 CN¥4.590 0.00% 7,424,500
26-08-07 CN¥4.590 +1.32% 10,291,100
26-08-06 CN¥4.530 -1.52% 7,663,400

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock